메뉴 건너뛰기




Volumn 36, Issue 11-12, 2004, Pages 823-828

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; DIDANOSINE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEOPTERIN; STAVUDINE; VIRUS RNA;

EID: 11344272928     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410025320     Document Type: Article
Times cited : (42)

References (31)
  • 3
    • 0032485436 scopus 로고    scopus 로고
    • Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
    • Cinque P, Vago L, Ceresa D, Mainini F, Terreni MR, Vagani A, et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. Aids 1998; 12: 389-94.
    • (1998) Aids , vol.12 , pp. 389-994
    • Cinque, P.1    Vago, L.2    Ceresa, D.3    Mainini, F.4    Terreni, M.R.5    Vagani, A.6
  • 4
    • 0030901509 scopus 로고    scopus 로고
    • Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
    • Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175: 963-6.
    • (1997) J. Infect. Dis. , vol.175 , pp. 963-966
    • Brew, B.J.1    Pemberton, L.2    Cunningham, P.3    Law, M.G.4
  • 5
    • 17044457875 scopus 로고    scopus 로고
    • ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results
    • Murphy RL, Brun S, Hicks C, Eron JJ, Gulick R, King M, et al. ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. Aids 2001; 15: F1-9.
    • (2001) Aids , vol.15
    • Murphy, R.L.1    Brun, S.2    Hicks, C.3    Eron, J.J.4    Gulick, R.5    King, M.6
  • 6
    • 0031972548 scopus 로고    scopus 로고
    • HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir
    • Gisslén M, Norkrans G, Svennerholm B, Hagberg L. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir. Aids 1998; 12: 114-6.
    • (1998) Aids , vol.12 , pp. 114-116
    • Gisslén, M.1    Norkrans, G.2    Svennerholm, B.3    Hagberg, L.4
  • 7
    • 0030791962 scopus 로고    scopus 로고
    • Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir
    • Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. Aids 1997; 11: 1302-3.
    • (1997) Aids , vol.11 , pp. 1302-1303
    • Pialoux, G.1    Fournier, S.2    Moulignier, A.3    Poveda, J.D.4    Clavel, F.5    Dupont, B.6
  • 8
    • 0027122957 scopus 로고
    • 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
    • RR-17
    • 3 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Weekly Rep 1992; 41: RR-17.
    • (1992) MMWR Morb. Mortal. Weekly Rep. , vol.41
  • 9
    • 0023025943 scopus 로고
    • Measurement of beta-2-microglobulin in human cerebrospinal fluid by ELISA technique
    • Bjerrum OW, Lage S, Hansen OE. Measurement of beta-2-microglobulin in human cerebrospinal fluid by ELISA technique. Acta Neurol Scand 1986; 74: 177-80.
    • (1986) Acta Neurol. Scand. , vol.74 , pp. 177-180
    • Bjerrum, O.W.1    Lage, S.2    Hansen, O.E.3
  • 11
    • 0031588522 scopus 로고    scopus 로고
    • Indinavir in cerebrospinal fluid of HIV-1 infected patients
    • Stable L, Martin C, Svensson JO, Sonnerborg A. Indinavir in cerebrospinal fluid of HIV-1 infected patients. Lancet 1997; 350: 1823.
    • (1997) Lancet , vol.350 , pp. 1823
    • Stable, L.1    Martin, C.2    Svensson, J.O.3    Sonnerborg, A.4
  • 12
    • 0033928524 scopus 로고    scopus 로고
    • Indinavir population pharmacokinetics in plasma and cerebrospinal fluid
    • The HIV Neurobehavioral Research Center Group
    • Letendre SL, Capparelli EV, Ellis RJ, McCutchan JA. Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. Antimicrob Agents Chemother 2000; 44: 2173-5.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 2173-2175
    • Letendre, S.L.1    Capparelli, E.V.2    Ellis, R.J.3    McCutchan, J.A.4
  • 13
    • 0032560373 scopus 로고    scopus 로고
    • Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
    • Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, et al. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 1998; 351: 1547-51.
    • (1998) Lancet , vol.351 , pp. 1547-1551
    • Foudraine, N.A.1    Hoetelmans, R.M.2    Lange, J.M.3    de Wolf, F.4    van Benthem, B.H.5    Maas, J.J.6
  • 15
  • 16
    • 0032585875 scopus 로고    scopus 로고
    • Pharmacokinetics of [(14)C] abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1 infected adults: A mass balance study
    • McDowell JA, Chittick GE, Ravitch JR, Polk RE, Kerkering TM, Stein DS. Pharmacokinetics of [(14)C] abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1 infected adults: a mass balance study. Antimicrob Agents Chemother 1999; 43: 2855-61.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 2855-2861
    • McDowell, J.A.1    Chittick, G.E.2    Ravitch, J.R.3    Polk, R.E.4    Kerkering, T.M.5    Stein, D.S.6
  • 17
    • 0032135991 scopus 로고    scopus 로고
    • Neurological efficacy of stavudine, zidovudine, and lamivudine
    • Gisslén M, Svennerholm B, Fuchs D, Hagberg L. Neurological efficacy of stavudine, zidovudine, and lamivudine. Lancet 1998; 352: 402-3.
    • (1998) Lancet , vol.352 , pp. 402-403
    • Gisslén, M.1    Svennerholm, B.2    Fuchs, D.3    Hagberg, L.4
  • 18
    • 0024376631 scopus 로고
    • Declining incidence of AIDS dementia complex after introduction of zidovudine treatment
    • Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 1989; 299: 819-21.
    • (1989) Br. Med. J. , vol.299 , pp. 819-821
    • Portegies, P.1    de Gans, J.2    Lange, J.M.3    Derix, M.M.4    Speelman, H.5    Bakker, M.6
  • 19
    • 0031034408 scopus 로고    scopus 로고
    • The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine
    • Gisslén M, Norkrans G, Svennerholm B, Hagberg L. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis 1997; 175: 434-7.
    • (1997) J. Infect. Dis. , vol.175 , pp. 434-437
    • Gisslén, M.1    Norkrans, G.2    Svennerholm, B.3    Hagberg, L.4
  • 20
    • 0032875534 scopus 로고    scopus 로고
    • Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1 infected patients receiving combination therapy
    • Tashima KT, Caliendo AM, Ahmad M, Gormley JM, Fiske WD, Brennan JM, Flanigan TP. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1 infected patients receiving combination therapy. J Infect Dis 1999; 180: 862-4.
    • (1999) J. Infect. Dis. , vol.180 , pp. 862-864
    • Tashima, K.T.1    Caliendo, A.M.2    Ahmad, M.3    Gormley, J.M.4    Fiske, W.D.5    Brennan, J.M.6    Flanigan, T.P.7
  • 21
    • 0006848674 scopus 로고    scopus 로고
    • Estimation of nevirapine exposure within the cerebrospinal fluid using CSF: Plasma area under the curve ratios
    • Sixth Conference on Retroviruses and Oppurtunistic Infections. Chicago, IL, January-February [Abstract no. 406]
    • Kearney B, Price R, Sheiner L. Estimation of nevirapine exposure within the cerebrospinal fluid using CSF:plasma area under the curve ratios. Sixth Conference on Retroviruses and Oppurtunistic Infections. Chicago, IL, January-February 1999 [Abstract no. 406].
    • (1999)
    • Kearney, B.1    Price, R.2    Sheiner, L.3
  • 22
    • 0033936554 scopus 로고    scopus 로고
    • Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
    • van Praag RM, Weverling GJ, Portegies P, Jurriaans S, Zhou XJ, Turner-Foisy ML, et al. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. Aids 2000; 14: 1187-94.
    • (2000) Aids , vol.14 , pp. 1187-1194
    • van Praag, R.M.1    Weverling, G.J.2    Portegies, P.3    Jurriaans, S.4    Zhou, X.J.5    Turner-Foisy, M.L.6
  • 25
    • 0036184628 scopus 로고    scopus 로고
    • Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations
    • Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials 2002; 3: 27-35.
    • (2002) HIV Clin. Trials , vol.3 , pp. 27-35
    • Lafeuillade, A.1    Solas, C.2    Halfon, P.3    Chadapaud, S.4    Hittinger, G.5    Lacarelle, B.6
  • 26
    • 12244294518 scopus 로고    scopus 로고
    • Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients
    • Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2003; 47: 238-43.
    • (2003) Antimicrob. Agents Chemother. , vol.47 , pp. 238-243
    • Solas, C.1    Lafeuillade, A.2    Halfon, P.3    Chadapaud, S.4    Hittinger, G.5    Lacarelle, B.6
  • 27
    • 0033853163 scopus 로고    scopus 로고
    • Cerebrospinal fluid and plasma viral load in HIV-1 infected patients with various anti-retroviral treatment regimens
    • Gisslén M, Svennerholm B, Norkrans G, Franzen C, Sall C, Svensson R, et al. Cerebrospinal fluid and plasma viral load in HIV-1 infected patients with various anti-retroviral treatment regimens. Scand J Infect Dis 2000; 32: 365-9.
    • (2000) Scand. J. Infect. Dis. , vol.32 , pp. 365-369
    • Gisslén, M.1    Svennerholm, B.2    Norkrans, G.3    Franzen, C.4    Sall, C.5    Svensson, R.6
  • 28
    • 0033178428 scopus 로고    scopus 로고
    • Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection
    • Gisslén M, Fuchs D, Svennerholm B, Hagberg L. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 1999; 21: 271-6.
    • (1999) J. Acquir. Immune Defic. Syndr. , vol.21 , pp. 271-276
    • Gisslén, M.1    Fuchs, D.2    Svennerholm, B.3    Hagberg, L.4
  • 29
  • 30
    • 0021264311 scopus 로고
    • Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma
    • Huber C, Batchelor R, Fuchs D, Hause A, Lang A, Niederwieser D. Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-6.
    • (1984) J. Exp. Med. , vol.160 , pp. 310-316
    • Huber, C.1    Batchelor, R.2    Fuchs, D.3    Hause, A.4    Lang, A.5    Niederwieser, D.6
  • 31
    • 0037045074 scopus 로고    scopus 로고
    • Continuing intrathecal immunoactivation despite 2 y of effective antiretroviral therapy against HIV-1 infection
    • Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslén M. Continuing intrathecal immunoactivation despite 2 y of effective antiretroviral therapy against HIV-1 infection. Aids 2002; 16: 2145-9.
    • (2002) Aids , vol.16 , pp. 2145-2149
    • Abdulle, S.1    Hagberg, L.2    Svennerholm, B.3    Fuchs, D.4    Gisslén, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.